Studies

Com-COV 3

Comparing COVID-19 Vaccine Schedule Combinations in Adolescents

Com-COV3 aims to find out how well young people (aged 12-16 years) respond to two doses of COVID-19 vaccine, comparing three different vaccines at different doses.

Visit Study Website

Preg-CoV

Evaluating COVID-19 Vaccines in Pregnancy

Ongoing global studies so far have found that pregnant women are more likely to develop severe COVID-19 disease compared to non-pregnant women of the same age. The trial will compare vaccines that are currently being used for the UK vaccination programme, as well as new vaccines as they are approved.

Visit Study Website

COV-Boost

Comparing COVID-19 Booster Vaccinations

University Hospital Southampton NHS Foundation Trust’s COV-Boost vaccine trial is studying the use of seven different COVID-19 vaccines when given as a third dose.

Visit Study Website

Com-COV

Comparing COVID-19 Vaccine Schedule Combinations

The Oxford Vaccine Group’s Com-Cov vaccine trial is studying the use of different combinations of approved COVID-19 vaccines for the first and second immunisation doses.

Visit Study Website

ComFluCOV

Combining Influenza and COVID-19 vaccination

The study will look at the safety, as well as the immune responses, when giving currently approved COVID-19 vaccines at the same time as the recommended influenza (flu) vaccines from the 2020/21 flu season programme.

Visit Study Website

Com-COV 2

Comparing COVID-19 Vaccine Schedule Combinations

The Oxford Vaccine Group’s Com-Cov vaccine trial is studying the use of different combinations of approved COVID-19 vaccines for the first and second immunisation doses.

Visit Study Website

What's the STORY?

Serum Testing Of Representative Youngsters

The Oxford Vaccine Group is researching a new way of surveying how well protected we are from infectious diseases by collecting blood samples from people who represent different groups across society.

Learn More

OpTIMUM

Optimising the Timing of Whooping Cough Immunisation in MUMs

A multicentre study to evaluate the impact of timing of whooping cough (pertussis) vaccination in pregnancy, with participants randomised to receive whooping cough vaccination at one of three time points in pregnancy.

Visit Study Website

iMAP3

Immunising Mums Against Pertussis 3

A multi-centre observational cohort study comparing children whose mothers were randomised to one of two pertussis-containing vaccines in pregnancy as part of the iMAP2 study (REPEVAX or BOOSTRIX-IPV) or who received no pertussis- containing vaccine in pregnancy

Visit Study Website